AI-based Low Dose CBCT Reconstruction for Clinical Application

Condition(s) studied

Investigational drug(s) / intervention(s)

AI-based low dose CBCT reconstructed images system: Participants in the experimental group undergo AI-based low dose (radiation dose is 1/6th of the dose used in the clinic) CBCT reconstructed images guided lung puncture procedures.

Conventional CBCT images system: Participants in the experimental group undergo conventional CBCT images guided lung puncture procedures.

Study summary

The goal of this clinical trial is to learn if AI-based low dose CBCT reconstructed images can guide lung puncture effectively. The main questions it aims to answer are:

1. Does the AI-based low dose CBCT reconstruction model reconstruct high quality images?
2. Is it possible that low-dose CBCT reconstructed images can guide lung puncture procedures without compromising the efficiency of the procedure? Researchers will compare AI-based low dose CBCT reconstructed images to a placebo (conventional CBCT images) to see if AI-based low dose CBCT reconstructed image can guide lung puncture procedures without compromising the efficiency of the procedure.

Participants will:

1. Undergo lung puncture under AI-based low dose CBCT reconstructed images guidance or under conventional CBCT images
2. Be followed up for 1 week postoperative to obtain patient complications

Eligibility

Primary outcome measure(s)

• Number of puncture needles of participants undergoing percutaneous lung puncture procedures. — From enrollment to the end of the lung puncture procedure.
  The number of punctures was defined as the number of punctures performed throughout the percutaneous lung puncture procedure.

Trial sites (3)

More Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trials in China

Other trials for the same condition